Investor Profile: Agronomics — Thesis, Cheque Size & How to Apply

Agronomics is a listed venture investor focused on cellular agriculture, the field of producing agricultural products directly from cell cultures rather than from animals or traditional farming. Listed on the London Stock Exchange under the ticker ANIC and founded in 2018, it gives public-market investors exposure to the same technologies that private venture funds back. For founders in cultivated meat, precision fermentation and related fields, Agronomics funding comes from a listed balance sheet with a long-term view.

Thesis: food from cells, not farms

Agronomics invests in companies developing sustainable protein and food technologies across fermentation and alternative proteins. Its portfolio spans cultivated beef, pork, chicken, seafood, egg proteins, dairy, palm oil, cocoa, cotton and leather, as well as a contract manufacturer for fermentation commercialisation. The underlying bet is that decoupling food production from livestock and land can cut environmental impact while meeting rising demand for protein, and that the winning technologies will be those that reach cost parity and regulatory approval first.

Because Agronomics is listed, its approach differs from a conventional venture fund. It invests its own capital alongside other investors in portfolio rounds and reports its portfolio and net asset value publicly.

Fund size and cheque size

Agronomics does not operate as a conventional closed venture fund, so a single fund size is not publicly disclosed in the usual sense. Instead it deploys capital from its listed balance sheet into portfolio companies, with individual investments varying widely by stage and opportunity. Public disclosures illustrate the range: it invested £7.4 million in Liberation Labs' convertible note round, £1 million in Good Dog Food's £3.6 million seed round, and smaller early amounts such as US$2.2 million in California Cultured. Founders should therefore treat cheque size as deal-dependent rather than fixed.

Notable portfolio companies

Agronomics reports an established portfolio of more than 20 investments in cellular agriculture. Named holdings include BlueNalu in cultivated seafood, Mosa Meat in cultivated meat, Formo in animal-free dairy, Liberation Labs in precision fermentation infrastructure, Rebellyous Foods in plant-based chicken, Solar Foods, Onego Bio in animal-free egg protein, Clean Food Group, CellX in China, and California Cultured in cultivated cocoa. Its portfolio companies have reached notable milestones, including United States regulatory approvals for cultivated chicken from Upside Foods and Eat Just, and regulatory clearance in China for All G Foods.

Partners and approach

Agronomics was co-founded by Jim Mellon, its executive director, and Anthony Chow. Mellon has argued publicly that United States food safety regulation is among the most stringent in the world, and that approvals there create a framework other jurisdictions can follow. The firm tracks its portfolio closely, including fermentation capacity, where Liberation Labs' purpose-built infrastructure is seen as critical to solving the capacity shortage facing precision fermentation companies.

How to apply for funding

No public application portal was found on Agronomics' website. Founders can approach the firm through its official website at agronomics.im, where its portfolio and investment focus are published in detail. A strong approach should show which part of the cellular agriculture value chain the company occupies, progress toward regulatory approval and cost parity, and the size and stage of the round, since Agronomics invests alongside other venture investors rather than leading every round.